DR. PRAMOD REDDY GANTA MD NPI 1841236395

NPI Details

DR. Pramod Reddy Ganta, MD is a hematology and oncology internal medicine in Anderson, SC with 26 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Pramod Reddy Ganta, MD NPI is 1841236395. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

2508 N MAIN ST STE G
ANDERSON, SC
ZIP 29621
Phone: (864) 540-8430
Fax: (866) 421-1896

The NPI 1841236395 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, heparin sodium, (heparin lock flush), per 10 units (HCPCS:J1642)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Unclassified drugs (HCPCS:J3490)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, furosemide, up to 20 mg (HCPCS:J1940)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Blood glucose (sugar) level (HCPCS:82947)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Extended patient service without direct patient contact, first hour (HCPCS:99358)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month (HCPCS:99491)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Injection of drug or substance into vein (HCPCS:96374)
• Extended patient service without direct patient contact, each additional 30 minutes (HCPCS:99359)
• Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring (HCPCS:M0245)
• Injection, bamlanivimab and etesevimab, 2100 mg (HCPCS:Q0245)
• Urinalysis, manual test (HCPCS:81002)

The enumeration date for this NPI number is 6/22/2006 and was last updated on 8/16/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.